Search

Displaying results 7611 - 7620 of 10000 in total
  1. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    Ambasilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ambasilide is a sematilide derivative class III antiarrhythmic. … Ambasilide has a monoisotopic molecular weight of 335.2 Da.

  2. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    Bitipazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Bitipazone is a anti-inflammatory analgesic, phenylbutazone derivative. … Bitipazone has a monoisotopic molecular weight of 454.27 Da.

  3. Drug

    Canocapavir

    go.drugbank.com/drugs/DB21570
    Experimental

    Canocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor. … Canocapavir has a monoisotopic molecular weight of 561.08 Da.

  4. Drug

    Emzeltrectinib

    go.drugbank.com/drugs/DB21605
    Experimental

    Emzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor. … Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da.

  5. Drug

    Zavondemstat

    go.drugbank.com/drugs/DB21608
    Experimental

    Zavondemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor. … Zavondemstat has a monoisotopic molecular weight of 431.22 Da.

  6. Drug

    TY027

    go.drugbank.com/drugs/DB16500
    Investigational

  7. Drug

    Vedolizumab

    go.drugbank.com/drugs/DB09033
    ApprovedInvestigational

    Vedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation implicated in diseases like ulcerative … [A261576] Vedolizumab is administered by IV infusion over a period of 30 minutes; after the first dose, it is given again at two and six weeks and then every 8 weeks thereafter.

    Products: ENTYVIO Pen
  8. Drug

    Gabexate

    go.drugbank.com/drugs/DB12831
    Investigational

    Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. … Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.[A19218,A19219,A19220]

  9. Drug

    IL15-NK Cell

    go.drugbank.com/drugs/DB15725
    Investigational

    In particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.

  10. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Omberacetam is a piracetam type amide type nootrope agent. … Omberacetam has a monoisotopic molecular weight of 318.16 Da.